oxybutynin has been researched along with Respiratory Syncytial Virus Infections in 1 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
Respiratory Syncytial Virus Infections: Pneumovirus infections caused by the RESPIRATORY SYNCYTIAL VIRUSES. Humans and cattle are most affected but infections in goats and sheep have been reported.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hervé, PL | 1 |
Descamps, D | 1 |
Deloizy, C | 1 |
Dhelft, V | 1 |
Laubreton, D | 1 |
Bouguyon, E | 1 |
Boukadiri, A | 1 |
Dubuquoy, C | 1 |
Larcher, T | 1 |
Benhamou, PH | 1 |
Eléouët, JF | 1 |
Bertho, N | 1 |
Mondoulet, L | 1 |
Riffault, S | 1 |
1 other study available for oxybutynin and Respiratory Syncytial Virus Infections
Article | Year |
---|---|
Non-invasive epicutaneous vaccine against Respiratory Syncytial Virus: Preclinical proof of concept.
Topics: Administration, Cutaneous; Animals; Female; Langerhans Cells; Mice; Respiratory Syncytial Virus Infe | 2016 |